Delayed readings of a standard screening patch test tray: Frequency of “lost,” “found,” and “persistent” reactions

Taylor, James S.; Evey, Phyllis

doi:10.1053/ajcd.2000.8008

Cited by 32 publications

(26 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of interest, in the year‐long study, fusidic acid was on two of three occasions positive on the second reading only. Neomycin‐positive reactions are usually only found on the second reading, 17 and it may be that fusidic acid reacts similarly.…”

Section: Discussionmentioning

confidence: 99%

Comparative frequency of patch test reactions to topical antibiotics

et al. 2002

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Comparative frequency of patch test reactions to topical antibiotics

et al. 2002

View full text Add to dashboard Cite

show abstract

“…In patch tests with a broad panel of allergens, up to 15 % of positive reactions are not detected if there is no subsequent reading after day 3 (15 % ; 13.5 % ; 12.8 % ; 3 % .…”

Section: Duration Of Exposurementioning

confidence: 99%

“…2000 (4 according to OCEBM) ; Madsen & Andersen 2012 (4 according to OCEBM) ; Saino et al. 1995 (4 according to OCEBM) …”

Section: Duration Of Exposurementioning

confidence: 99%

“…1989 (4 according to OCEBM) ; Madsen & Andersen 2012 (4 according to OCEBM) ; Matiz et al. 2011 (3b according to OCEBM) ] –Formaldehyde, formaldehyde releaser, formaldehyde resins [Dickel et al. 2000 (4 according to OCEBM) ; Jonker & Bruynzeel 2000 (4 according to OCEBM) ; MacFarlane et al.…”

Section: Duration Of Exposurementioning

confidence: 99%

“…2000 (4 according to OCEBM) ; Madsen & Andersen 2012 (4 according to OCEBM) ; MacFarlane et al. 1989 (3b according to OCEBM) ] –(Dental) metals [Koch & Bahmer 1999 (3b according to OCEBM) ] …”

Section: Duration Of Exposurementioning

confidence: 99%

See 2 more Smart Citations

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1

Mahler

Nast

Bauer

et al. 2019

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Summary Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board‐certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed‐type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physicians, nursing staff as well as patient representatives. The systematic methodological approach and appraisal of evidence upon which the recommendations are based are outlined in a separate method report that also contains evidence tables. The guidelines address general aspects of patch testing as well as medicolegal issues. The recommendations given relate to topics such as the indication for patch testing, informed patient consent, as well as the choice of test substances, test chambers and test site, duration of exposure, reading times and interpretation of test reactions. Furthermore, recommendations are provided with respect to endogenous and exogenous factors, specific patient groups (children, pregnant women, immunosuppressed individuals) as well as possible risks and adverse events associated with patch testing using contact allergens. Note: This publication is part 1 of the short version of the S3 guidelines for “Epicutaneous patch testing using contact allergens and drugs” (registry no. 013 – 018; date: March 20, 2019; valid until December 31, 2021). Part 2 of the short version will be published in the next issue. The long version of these guidelines can be accessed at http://www.awmf.org. The method report is available as online publication (https://www.awmf.org/leitlinien/detail/ll/013-018.html) and contains the evidence tables in its appendix.

show abstract

p‐tert‐Butylphenol‐Formaldehyd‐Kondensationsprodukte (niedermolekular) [MAK Value Documentation in German language, 2004]

2012

The MAK‐Collection for Occupational Health and Safety

View full text Add to dashboard Cite

show abstract

Delayed readings of a standard screening patch test tray: Frequency of “lost,” “found,” and “persistent” reactions

Abstract: Two patch test readings are necessary, followed by a final interpretation.

Cited by 32 publications

References 0 publications

Comparative frequency of patch test reactions to topical antibiotics

Comparative frequency of patch test reactions to topical antibiotics

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1

p‐tert‐Butylphenol‐Formaldehyd‐Kondensationsprodukte (niedermolekular) [MAK Value Documentation in German language, 2004]

Contact Info

Product

Resources

About